clinical trial Archive — Page 2 of 16
-
February 6, 2026
Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID
The public health burden of long COVID is estimated to be the largest seen from an emerging disease in the past century, yet there remain no effective interventions. -
February 5, 2026
‘Liberation’ from acute dialysis may enhance recovery of kidney function
Researchers at Vanderbilt Health and three other centers compared conventional dialysis to a conservative dialysis strategy. -
February 4, 2026
Clinical trial led by Vanderbilt Health seeks to refine lung cancer biopsy standards
The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive. -
December 10, 2025
Sedative choice could improve outcomes for breathing tube patients
It's the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past. -
December 8, 2025
Interim data reported for multiple myeloma off-the-shelf CAR-T therapy
Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells. -
December 2, 2025
Ketamine fails surgical recovery trial
In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery. -
December 2, 2025
Study seeks to determine best way to treat myopia in children
Researchers hope to slow the progression of this chronic eye disease that affects approximately 40% of the U.S. population.